Recent studies have focused on the overlap of GLP-1|GIP|GCGR stimulant therapies and DA communication. While GCGR stimulators are increasingly employed for treating type 2 diabetes, their potential effects on https://monicalmnr120235.blog5.net/94112870/novel-gip-stimulators-and-da-influence-a-comparative-overview